Skip to main content

Aspira Women's Health Inc.

AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000926617

No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Aspira Women's Health Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of AWHL: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders4522−23
SharesConverted for a 1-for-15 split591.4K530.0K−61.5K (−10.4%)
Value$3.25M$1.75M−$1.49M (−46.0%)

New holders (1)

Institutions that held Aspira Women's Health Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to AWHL in Q2 2023
InstitutionSharesValue% of portfolio
Castleview Partners, LLC1,316$4.36K0.00%

Sold out (24)

Institutions that held Aspira Women's Health Inc. at the end of Q1 2023 and filed for Q2 2023 without it.